A Causal Mediation Approach to Account for Interaction of Treatment and Intercurrent Events: Using Hypothetical Strategy

Author:

Wu Kunpeng12,Zhang Xiangliang12ORCID,Zheng Meng12,Zhang Jianghui12,Chen Wen12ORCID

Affiliation:

1. Department of Medical Statistics, School of Public Health Sun Yat‐sen University Guangzhou China

2. Center for Migrant Health Policy Sun Yat‐sen University Guangzhou China

Abstract

ABSTRACTHypothetical strategy is a common strategy for handling intercurrent events (IEs). No current guideline or study considers treatment–IE interaction to target the estimand in any one IE‐handling strategy. Based on the hypothetical strategy, we aimed to (1) assess the performance of three estimators with different considerations for the treatment–IE interaction in a simulation and (2) compare the estimation of these estimators in a real trial. Simulation data were generalized based on realistic clinical trials of Alzheimer's disease. The estimand of interest was the effect of treatment with no IE occurring under the hypothetical strategy. Three estimators, namely, G‐estimation with and without interaction and IE‐ignored estimation, were compared in scenarios where the treatment–IE interaction effect was set as −50% to 50% of the main effect. Bias was the key performance measure. The real case was derived from a randomized trial of methadone maintenance treatment. Only G‐estimation with interaction exhibited unbiased estimations regardless of the existence, direction or magnitude of the treatment–IE interaction in those scenarios. Neglecting the interaction and ignoring the IE would introduce a bias as large as 0.093 and 0.241 (true value, −1.561) if the interaction effect existed. In the real case, compared with G‐estimation with interaction, G‐estimation without interaction and IE‐ignored estimation increased the estimand of interest by 33.55% and 34.36%, respectively. This study highlights the importance of considering treatment–IE interaction in the estimand framework. In practice, it would be better to include the interaction in the estimator by default.

Funder

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Wiley

Reference38 articles.

1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use “Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials ”(2019).

2. Evaluating How Clear the Questions Being Investigated in Randomised Trials Are: Systematic Review of Estimands;Cro S.;BMJ,2022

3. Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods;Parra C. O.;Statistics in Biopharmaceutical Research,2023

4. Choice of Estimand and Analysis Methods in Diabetes Trials With Rescue Medication;Holzhauer B.;Pharmaceutical Statistics,2015

5. Adverse Drug Reactions as Cause of Admission to Hospital: Prospective Analysis of 18 820 Patients;Pirmohamed M.;BMJ,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3